|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.10 EUR | +0.37% |
|
-0.74% | -9.40% |
| 04-22 | Boiron SA Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 04-06 | Boiron SA announces Annual dividend, payable on June 05, 2026 | CI |
| Market Cap | 477M 546M 440M 407M 772M 52.06B 785M 5.26B 2.07B 25.65B 2.05B 2B 88.17B | P/E 2024 |
41x | P/E 2025 | 16.1x |
|---|---|---|---|---|---|
| Enterprise Value | 430M 491M 396M 366M 694M 46.84B 706M 4.73B 1.86B 23.08B 1.84B 1.8B 79.33B | EV / Sales 2024 |
0.85x | EV / Sales 2025 | 0.95x |
| Free-Float |
19.96% | Yield 2024 |
4.48% | Yield 2025 | 4.46% |
| 1 week | -0.73% | ||
| Current month | -2.52% | ||
| 1 month | -4.24% | ||
| 3 months | +2.26% | ||
| 6 months | -9.06% | ||
| Current year | -9.06% |
| 1 week | 27 | 27.3 | |
| 1 month | 27 | 28.2 | |
| 3 years | 20.5 | 55.9 | |
| 5 years | 20.5 | 55.9 | |
| 10 years | 20.5 | 91.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Houdayer
CEO | Chief Executive Officer | 57 | 01/01/2025 |
Frédéric Riou
CTO | Chief Tech/Sci/R&D Officer | - | - |
Isabelle Chanel
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Thierry Boiron
CHM | Chairman | 65 | 01/07/2011 |
| Director/Board Member | 54 | 10/03/2010 | |
| Director/Board Member | 51 | 23/05/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.37% | -0.74% | +21.80% | -45.91% | 546M | ||
| +0.95% | -0.08% | -12.82% | -8.16% | 12.85B | ||
| +2.42% | +1.37% | -33.43% | -54.80% | 4.79B | ||
| -0.02% | -0.64% | -6.89% | -5.76% | 4.4B | ||
| -7.84% | -7.31% | +12.48% | -9.74% | 3.68B | ||
| +2.11% | -0.70% | +4.02% | -37.69% | 3.82B | ||
| -0.58% | +6.63% | -8.69% | -13.03% | 3.26B | ||
| +0.28% | +0.57% | -11.39% | +2.92% | 3.1B | ||
| -0.77% | +1.24% | -7.85% | -23.20% | 2.41B | ||
| -0.32% | +4.78% | -5.40% | +44.70% | 1.8B | ||
| Average | -0.42% | -1.14% | -4.82% | -15.07% | 4.46B | |
| Weighted average by Cap. | -0.01% | -1.26% | -9.20% | -14.91% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 488M 557M 450M 415M 788M 53.16B 801M 5.37B 2.11B 26.19B 2.09B 2.05B 90.03B | 501M 573M 462M 427M 810M 54.64B 824M 5.52B 2.17B 26.92B 2.15B 2.1B 92.53B |
| Net income | 11.34M 12.96M 10.46M 9.66M 18.32M 1.24B 18.63M 125M 49.06M 609M 48.66M 47.6M 2.09B | 32.64M 37.32M 30.11M 27.81M 52.77M 3.56B 53.65M 360M 141M 1.75B 140M 137M 6.03B |
| Net Debt | -49.74M -56.86M -45.88M -42.37M -80.4M -5.42B -81.75M -548M -215M -2.67B -214M -209M -9.18B | -47.86M -54.71M -44.14M -40.77M -77.36M -5.22B -78.66M -527M -207M -2.57B -205M -201M -8.84B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change |
|---|---|---|
| 10/07/26 | €27.10 | +0.37% |
| 09/07/26 | €27.00 | 0.00% |
| 08/07/26 | €27.00 | 0.00% |
| 07/07/26 | €27.00 | -1.10% |
| 06/07/26 | €27.30 | 0.00% |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- BOI Stock
- BON Stock
Select your edition
All financial news and data tailored to specific country editions
















